PER 1.41% 7.0¢ percheron therapeutics limited

UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-26

  1. 35,729 Posts.
    lightbulb Created with Sketch. 554
    Generally small AX biotech's don't present anything at "The" JPMHC per se.

    JPM "week" though, there a plenty of smaller offshoot conferences around the city where ASX companies find themselves as has ANP amongst others in the past - Biotech Showcase etc

    This year being virtual though not so sure.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.